Found: 5
Select item for more details and to access through your institution.
Selective inhibitory effects of HYIpro‐3‐1 on CYP1A2 in human liver microsomes.
- Published in:
- Biopharmaceutics & Drug Disposition, 2021, v. 42, n. 1, p. 35, doi. 10.1002/bdd.2259
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic model of renally cleared antibacterial drugs in Chinese renal impairment patients.
- Published in:
- Biopharmaceutics & Drug Disposition, 2021, v. 42, n. 1, p. 24, doi. 10.1002/bdd.2258
- By:
- Publication type:
- Article
Lisdexamfetamine and amphetamine pharmacokinetics in oral fluid, plasma, and urine after controlled oral administration of lisdexamfetamine.
- Published in:
- Biopharmaceutics & Drug Disposition, 2021, v. 42, n. 1, p. 3, doi. 10.1002/bdd.2254
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Biopharmaceutics & Drug Disposition, 2021, v. 42, n. 1, p. 1, doi. 10.1002/bdd.2232
- Publication type:
- Article
Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity.
- Published in:
- Biopharmaceutics & Drug Disposition, 2021, v. 42, n. 1, p. 12, doi. 10.1002/bdd.2255
- By:
- Publication type:
- Article